AbrAxisOncology.com

Rating: 0 - 0 votes

Company Logo

Company Name

Company Contact

Website Analysis

• Home Page Analysis
• Web Presence
• Home Page Speed

Domain Whois

WHOIS information for AbrAxisOncology.com

Powered by who.is

Page Type

This page is about a company.

About AbrAxisOncology.com

Abraxane was approved in the United States* in January 2005 and is now approved in Canada for the treatment of metastatic breast cancer. FDA approval was based on pivotal phase III data that validated its use in the clinical setting. * ABRAXANE is a prescription medicine used to treat breast cancer that has spread to other parts of the body after treatment with certain other medicines has not worked.[[Category:Abraxis Oncology^®]]

Domain Resolution

This domain resolves to the following IP addresses:

• 209.123.182.86

×

Edit Page Image

×

Select image...

• jpeg, png, or gif
• one megabyte or smaller
• will be resized to 270 pixels wide

Close Save changes

×

Edit Name

×

Name

Close Save changes

×

Edit Contact Information

×

Address

City

State

Country

Postal Code

Phone

Fax

Email

Close Save changes

×

Edit Page Type

×

Page Type
Business / Organization Person Place Thing Other

Close Save changes

×

Map

×

×

Edit Page Rating

×

Your Rating

Close Save changes